Biotechnology Stocks
| # | Ultimi 7 Giorni | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 3674 |  KRRO Korro Bio, Inc. - Common Stock | 10.58 USD | +0.86% | +6.87% | -17.34% | -72.80% | 155.80 M USD | ||
| 3676 |  MOLN Molecular Partners AG - American Depositary Shares | 3.81 USD | +0.79% | -2.81% | -8.85% | +3.53% | 153.83 M USD | ||
| 3677 |  NERV Minerva Neurosciences, Inc - Common Stock | 3.22 USD | -1.53% | -2.13% | -21.46% | +33.06% | 153.75 M USD | ||
| 3682 |  ABOS Acumen Pharmaceuticals, Inc. - Common Stock | 2.10 USD | 0.00% | 0.00% | -24.73% | -8.30% | 151.87 M USD | ||
| 3695 |  CDXS Codexis, Inc. - Common Stock | 1.36 USD | -3.55% | -2.16% | -4.23% | -51.43% | 148.93 M USD | ||
| 3700 |  VYGR Voyager Therapeutics, Inc. - Common Stock | 2.37 USD | -4.05% | -12.87% | -25.94% | -49.03% | 146.03 M USD | ||
| 3706 |  ARMP Armata Pharmaceuticals, Inc. Common Stock | 3.85 USD | 0.00% | +11.92% | -30.51% | -52.88% | 143.15 M USD | ||
| 3708 |  AVXL Anavex Life Sciences Corp. - Common Stock | 1.54 USD | +0.65% | -18.09% | -43.17% | -83.70% | 142.75 M USD | ||
| 3713 |  RNA Atrium Therapeutics, Inc. - Common Stock | 8.26 USD | +4.16% | +0.49% | -20.88% | -88.26% | 141.29 M USD | ||
| 3724 |  OTLK Outlook Therapeutics, Inc. - Common Stock | 0.56 USD | -5.08% | -5.08% | -11.11% | +36.59% | 136.33 M USD | ||
| 3725 |  IPHA Innate Pharma S.A. - American Depositary Shares | 1.48 USD | -2.63% | -5.13% | -22.51% | -25.25% | 138.70 M USD | ||
| 3737 |  TLSA Tiziana Life Sciences Ltd - Common Shares | 1.13 USD | +2.73% | 0.00% | +17.71% | -47.69% | 136.17 M USD | ||
| 3750 |  ADAG Adagene Inc - ADS, each representing 1.25 | 2.78 USD | -1.07% | -6.08% | -21.25% | +40.40% | 131.73 M USD | ||
| 3754 |  SPRB Spruce Biosciences, Inc. - Common Stock | 45.54 USD | +2.57% | +3.20% | -18.11% | -74.38% | 130.88 M USD | ||
| 3762 |  NRXP NRX Pharmaceuticals, Inc. - Common Stock | 2.89 USD | -0.34% | -0.34% | -13.73% | +62.36% | 125.12 M USD | ||
| 3763 |  HUMA Humacyte, Inc. - Common Stock | 0.45 USD | -4.26% | -11.76% | -22.41% | -72.39% | 125.01 M USD | ||
| 3765 |  TNXP Tonix Pharmaceuticals Holding Corp. - Common Stock | 7.28 USD | -3.58% | -21.72% | -41.85% | -51.50% | 124.86 M USD | ||
| 3771 |  HURA TuHURA Biosciences, Inc. - Common Stock | 1.93 USD | -2.53% | -3.02% | -3.98% | -24.90% | 122.99 M USD | ||
| 3775 |  CBUS Cibus, Inc. - Class A Common Stock | 1.59 USD | -1.85% | -2.45% | +1.92% | +5.30% | 121.52 M USD | ||
| 3776 |  TNYA Tenaya Therapeutics, Inc. - Common Stock | 0.54 USD | +1.89% | -5.26% | -18.18% | -75.68% | 121.08 M USD |
Notizie Biotechnology Stocks
Il farmaco di Pharvaris per l’HAE mostra un sollievo più rapido
Raymond James avvia la copertura di Kymera Therapeutics con rating outperform
Raymond James avvia la copertura di Nektar con rating Market Perform
Palisade Bio: Raymond James avvia copertura con rating Outperform
Raymond James conferma il rating su Liquidia tra i ricorsi legali
Tenax Therapeutics sospende temporaneamente l’arruolamento nello studio LEVEL-2 di TNX-103 per modificare i criteri; richiede un incontro con la FDA
Ginkgo Bioworks supporterà NSF X-Labs con accesso al laboratorio
Gainers Biotechnology Stocks
 GRDX GridAI Technologies Corp. - Common Stock | 4.80 | +16.50% |
 CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 3.97 | +14.74% |
 IPSC Century Therapeutics, Inc. - Common Stock | 1.46 | +14.06% |
 ADCT ADC Therapeutics SA Common Shares | 1.59 | +11.97% |
 CDTTW CDT Equity Inc. - Warrant | 0.0117 | +11.43% |
 SRZN Surrozen, Inc. - Common Stock | 27.97 | +11.26% |
 ANL Adlai Nortye Ltd - American Depositary Shares | 15.51 | +10.39% |
 QNCX Quince Therapeutics, Inc. - Common Stock | 29.36 | +9.88% |
Losers Biotechnology Stocks
 SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0088 | -27.87% |
 YDESW YD Bio Limited - Warrants | 0.5000 | -23.08% |
 CRBU Caribou Biosciences, Inc. - Common Stock | 0.48 | -22.58% |
 TCRX TScan Therapeutics, Inc. - Common Stock | 0.23 | -17.86% |
 KALA KALA BIO, Inc. - Common Stock | 0.30 | -16.67% |
 BRTX BioRestorative Therapies, Inc. - Common Stock | 1.89 | -15.62% |
 MLEC Moolec Science SA - Ordinary Shares | 4.19 | -12.89% |
 LPCN Lipocine Inc. - Common Stock | 1.93 | -12.27% |